
How To Manage CLL Cancer Symptoms with Medical Marijuana
What is CLL Cancer? Chronic Lymphocytic Leukemia (CLL) is a type of blood cancer that affects the bone marrow and lymphatic system. It’s a slow-progressing
If You Are:
If You Are:
Understanding medical cannabis options for ADHD in Canada.
Living with Attention Deficit Hyperactivity Disorder (ADHD) can make everyday tasks feel overwhelming. As the most commonly diagnosed mental disorder in children, ADHD doesn’t just affect youth – it often continues into adulthood, creating ongoing challenges for many Canadians.
ADHD manifests differently in each person, but common symptoms include difficulty maintaining focus, hyperactivity, and impulsive behaviour. These symptoms can significantly impact daily functioning at school, work, and home.
Some common challenges faced by people with ADHD include:
Traditional treatments typically involve behavioural therapy and prescription medications, but these don’t work optimally for everyone. Side effects and limited effectiveness have led many Canadians to explore alternative options, including medical cannabis.
Research into cannabis for ADHD is growing, where patients and researchers are looking to use medical cannabis to manage and mitigate unwanted symptoms from ADHD.
The interaction between the endocannabinoid and dopamine systems in the brain is an area of ongoing scientific interest, especially for conditions like ADHD, where dopamine signalling is often irregular. Dopamine plays a key role in attention, motivation, and emotional regulation.
Some of the ways these systems may interact include:
These interactions between the endocannabinoid and dopaminergic systems are thought by some researchers to explain why certain individuals report changes in ADHD symptoms while working with healthcare professionals at Apollo Cannabis Clinics.
For Canadians struggling with ADHD, our doctors, healthcare practitioners, and medical cannabis specialists can provide support through personalized treatment plans.
Our team works with patients to address common ADHD symptoms, including:
We also look to assist patients who experience side effects from conventional ADHD medications, such as:
Traditional ADHD medications are typically stimulants like methylphenidate (Ritalin, Concerta) and amphetamine-based medications (Adderall, Vyvanse). These come with common concerns and side effects that can include physical side effects (appetite loss, insomnia), emotional side effects (irritability, mood swings), development of tolerance requiring dose increases, and concerns about long-term use. Alternative medications may have fewer risks and side effects, especially when used under the guidance of a healthcare practitioner.
Medical cannabis comes in various forms, each with different onset times, durations, and potential benefits for ADHD management. Finding the right option depends on your specific symptoms and lifestyle needs.
Oils and Tinctures
Dry Flower (for vaporization)
Capsules
Sprays
Many ADHD patients find that a combination approach works best – perhaps using a longer-acting oil or softgel for day-long symptom management with a faster-acting option for breakthrough symptoms.
Your healthcare provider can help determine which forms might work best based on your specific ADHD symptoms, daily schedule, medical history, and previous experience with cannabis.
If you’re considering medical cannabis for ADHD in Canada, here’s how to begin the process:
To determine if medical cannabis may be appropriate for your situation:
Our streamlined process makes it easy:
If approved, you’ll receive:
Our care doesn’t end with your prescription:
Starting medical cannabis treatment for ADHD is a significant decision. Our team of healthcare professionals specializes in cannabis medicine and can help you navigate this process safely and effectively through online prescription services across Canada.
An important consideration for anyone with ADHD is how medical cannabis might interact with other medications.
These interactions could affect how your medications work or potentially cause unwanted effects.
For your safety, always:
A comprehensive consultation with a healthcare provider at Apollo Cannabis is essential to ensure your treatment plan considers all aspects of your health, providing the best opportunity for successful symptom management with your online prescription.
Finding the right cannabis dosage for ADHD management is a personalized process requiring individualized guidance. While we recommend consulting with a healthcare professional for personalized advice, here are some general principles:
Starting Your Cannabis Treatment:
Gradual adjustments:
Tracking response:
These general guidelines are based on standards from The College of Family Physicians of Canada, but must be tailored to your specific needs by a healthcare provider during your online consultation.
Remember that cannabis affects everyone differently, and finding your optimal dosage may take time and patience. Working with a healthcare provider experienced in cannabis for ADHD can significantly improve your results when getting an online prescription in Canada.
Find everything you need to know about being a medical cannabis patient below.
Yes, medical cannabis is legal in Canada with a valid prescription. While ADHD isn’t automatically qualifying, healthcare providers can prescribe cannabis if they determine it may benefit your condition, especially when conventional treatments have been inadequate.
Not typically, though individual responses vary. Most patients who respond well to cannabis report improved focus and reduced hyperactivity. Finding the right strain, formulation, and dosage is crucial—products high in CBD with moderate THC often provide benefits without excessive psychoactive effects.
Some private insurers now offer coverage for medical cannabis, but coverage varies widely. Check with your insurance provider about specific policies. Many patients also qualify for medical cannabis expenses as tax deductions.
CBD (cannabidiol) and THC (tetrahydrocannabinol) affect ADHD symptoms differently:
Yes, many patients use medical cannabis alongside traditional ADHD medications. However, dosage adjustments may be necessary, and some interactions are possible. Always inform your healthcare provider about all medications you’re taking to ensure safe treatment.
Medical cannabis prescriptions in Canada typically need renewal every 3-12 months, depending on your healthcare provider’s recommendation and your treatment response. Regular follow-ups help ensure the treatment remains effective and appropriate.
This is a complex issue. While cannabis is generally not recommended for developing brains, in some cases, healthcare providers may consider it for those under 18 with severe symptoms when other treatments have failed. This requires careful consideration, parental involvement, and often consultation with specialists. Apollo has paediatricians who work with families and those of all ages to assess all factors and weigh the benefits versus the risks to see if medical cannabis could be a viable and beneficial option.
Not everyone responds the same way to medical cannabis. If you don’t experience benefits after a reasonable trial period or have unwanted side effects, your healthcare provider can help you explore other treatment options. The goal is to find what works for your specific needs.
While cannabis has a lower addiction potential than many substances, dependence is possible. Proper medical supervision, appropriate dosing, and regular evaluation help minimize this risk. CBD-dominant products typically have a very low potential for dependence.

What is CLL Cancer? Chronic Lymphocytic Leukemia (CLL) is a type of blood cancer that affects the bone marrow and lymphatic system. It’s a slow-progressing

Panic attacks are sudden episodes of intense discomfort or fear, typically ranging from 3-30 minutes. They are characterized by intense and often overlapping physical and

“We have demonstrated that regulated medical cannabis products can be incorporated into the care of cancer patients safely and effectively. After three months, the patients